Eigelberger M S, Clark O H
Department of Surgery, University of California San Francisco Medical Center at Mount Zion, USA.
Endocrinol Metab Clin North Am. 2000 Sep;29(3):479-502. doi: 10.1016/s0889-8529(05)70147-x.
Primary hyperparathyroidism, once thought to be a rare disease entity, is now a common problem. It can be diagnosed with nearly 100% accuracy. Surgical therapy is the only definitive cure for this disease, and normocalcemia is achieved in 95% of patients at initial operation when performed by an experienced surgeon. Even when the operation is initially unsuccessful, most of the patients with persistent disease can subsequently be cured. Although some clinicians have proposed that asymptomatic patients can be medically managed, the cost of such treatment, problems with patient compliance with long-term follow-up, the increased risk of premature death associated with primary hyperparathyroidism, and the low morbidity of operation support a liberal policy for exploration in most patients. The authors believe that nonoperative therapy should be limited to older patients with multiple comorbid conditions and minimal hypercalcemia and clinical manifestations.
原发性甲状旁腺功能亢进症,曾被认为是一种罕见的疾病实体,如今却是一个常见问题。其诊断准确率几乎可达100%。手术治疗是该病唯一的根治方法,由经验丰富的外科医生进行初次手术时,95%的患者可实现血钙正常。即便初次手术未成功,大多数持续性疾病患者随后也能治愈。尽管一些临床医生提议对无症状患者进行药物治疗,但这种治疗的成本、患者长期随访依从性的问题、原发性甲状旁腺功能亢进症相关的过早死亡风险增加以及手术的低发病率,都支持对大多数患者采取积极的探查策略。作者认为非手术治疗应仅限于患有多种合并症、高钙血症和临床表现轻微的老年患者。